121 related articles for article (PubMed ID: 38243838)
1. Loratadine is an anti-inflammatory agent against C. difficile toxin B.
Xie Y; Irwin S; Chupina Estrada A; Nelson B; Bullock A; Fontenot L; Feng H; Sun M; Koon HW
J Infect Dis; 2024 Jan; ():. PubMed ID: 38243838
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice.
Wang J; Ortiz C; Fontenot L; Mukhopadhyay R; Xie Y; Chen X; Feng H; Pothoulakis C; Koon HW
J Infect Dis; 2020 Apr; 221(10):1623-1635. PubMed ID: 31793629
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
[TBL] [Abstract][Full Text] [Related]
4. Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.
Koon HW; Wang J; Mussatto CC; Ortiz C; Lee EC; Tran DH; Chen X; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038278
[No Abstract] [Full Text] [Related]
5. Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.
Koon HW; Su B; Xu C; Mussatto CC; Tran DH; Lee EC; Ortiz C; Wang J; Lee JE; Ho S; Chen X; Kelly CP; Pothoulakis C
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G610-G623. PubMed ID: 27514478
[TBL] [Abstract][Full Text] [Related]
6. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
[TBL] [Abstract][Full Text] [Related]
7. Genistein Inhibits Clostridioides difficile Infection via Estrogen Receptors and Lysine-Deficient Protein Kinase 1.
Xie Y; Fontenot L; Estrada AC; Nelson B; Bullock A; Faull KF; Feng H; Sun M; Koon HW
J Infect Dis; 2023 Mar; 227(6):806-819. PubMed ID: 36628948
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D
Chan H; Li Q; Wang X; Liu WY; Hu W; Zeng J; Xie C; Kwong TNY; Ho IHT; Liu X; Chen H; Yu J; Ko H; Chan RCY; Ip M; Gin T; Cheng ASL; Zhang L; Chan MTV; Wong SH; Wu WKK
Autophagy; 2022 Sep; 18(9):2050-2067. PubMed ID: 34989311
[No Abstract] [Full Text] [Related]
9. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
11. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
[TBL] [Abstract][Full Text] [Related]
12. Cysteine Protease-Mediated Autocleavage of
Zhang Y; Li S; Yang Z; Shi L; Yu H; Salerno-Goncalves R; Saint Fleur A; Feng H
Cell Mol Gastroenterol Hepatol; 2018; 5(4):611-625. PubMed ID: 29930981
[TBL] [Abstract][Full Text] [Related]
13. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
14. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
[TBL] [Abstract][Full Text] [Related]
15. Toxin-positive
Etienne-Mesmin L; Chassaing B; Adekunle O; Mattei LM; Bushman FD; Gewirtz AT
Gut; 2018 May; 67(5):860-871. PubMed ID: 28219893
[TBL] [Abstract][Full Text] [Related]
16. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
[TBL] [Abstract][Full Text] [Related]
18. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
Peretz A; Tkhawkho L; Pastukh N; Brodsky D; Halevi CN; Nitzan O
BMC Infect Dis; 2016 Jun; 16():309. PubMed ID: 27334992
[TBL] [Abstract][Full Text] [Related]
19. [Preclinical and clinical properties of Bezlotoxumab (ZINPLAVA
Kinoshita K
Nihon Yakurigaku Zasshi; 2018; 152(1):39-50. PubMed ID: 29998951
[TBL] [Abstract][Full Text] [Related]
20. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
